DE3750422D1 - Translation von mrna. - Google Patents
Translation von mrna.Info
- Publication number
- DE3750422D1 DE3750422D1 DE3750422T DE3750422T DE3750422D1 DE 3750422 D1 DE3750422 D1 DE 3750422D1 DE 3750422 T DE3750422 T DE 3750422T DE 3750422 T DE3750422 T DE 3750422T DE 3750422 D1 DE3750422 D1 DE 3750422D1
- Authority
- DE
- Germany
- Prior art keywords
- mrna
- translation
- rna viruses
- omega
- enhancers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/10—Vectors comprising a special translation-regulating system regulates levels of translation
- C12N2840/105—Vectors comprising a special translation-regulating system regulates levels of translation enhancing translation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/60—Vectors comprising a special translation-regulating system from viruses
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868613481A GB8613481D0 (en) | 1986-06-04 | 1986-06-04 | Translation of mrna |
PCT/GB1987/000390 WO1987007644A1 (en) | 1986-06-04 | 1987-06-04 | TRANSLATION OF mRNA |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3750422D1 true DE3750422D1 (de) | 1994-09-29 |
DE3750422T2 DE3750422T2 (de) | 1994-12-15 |
Family
ID=10598884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3750422T Expired - Lifetime DE3750422T2 (de) | 1986-06-04 | 1987-06-04 | Translation von mrna. |
Country Status (8)
Country | Link |
---|---|
US (2) | US5489527A (de) |
EP (1) | EP0270611B1 (de) |
JP (2) | JP2814433B2 (de) |
AT (1) | ATE110412T1 (de) |
AU (1) | AU614062B2 (de) |
DE (1) | DE3750422T2 (de) |
GB (2) | GB8613481D0 (de) |
WO (1) | WO1987007644A1 (de) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5135855A (en) * | 1986-09-03 | 1992-08-04 | The United States Of America As Represented By The Department Of Health And Human Services | Rapid, versatile and simple system for expressing genes in eukaryotic cells |
CA1339841C (en) * | 1988-07-15 | 1998-04-28 | Robert L. Erwing | Synthesis of stereospecific enzyme by non-chromosomal transformation a host |
JPH0253491A (ja) * | 1988-08-17 | 1990-02-22 | Japan Tobacco Inc | ベクター及びその利用方法 |
EP0429483B1 (de) * | 1988-08-19 | 1997-11-12 | Seminis Vegetable Seeds, Inc. | Potyvirus-hüllproteingene und damit transformierte pflanzen |
EP0418695A1 (de) * | 1989-09-13 | 1991-03-27 | Ciba-Geigy Ag | Regulatorische DNA-Sequenz |
US5994526A (en) | 1996-06-21 | 1999-11-30 | Plant Genetic Systems | Gene expression in plants |
US6426185B1 (en) | 1998-01-16 | 2002-07-30 | Large Scale Biology Corporation | Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation |
US20030027173A1 (en) * | 1998-01-16 | 2003-02-06 | Della-Cioppa Guy | Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host |
US6303848B1 (en) | 1998-01-16 | 2001-10-16 | Large Scale Biology Corporation | Method for conferring herbicide, pest, or disease resistance in plant hosts |
US20020164585A1 (en) * | 1998-01-16 | 2002-11-07 | Sean Chapman | Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids |
EP1221481A4 (de) * | 1999-10-15 | 2004-12-08 | Yaeta Dr Endo | MATRIXMOLEKüL MIT BREITER ANWENDUNG UND HOCHEFFIZIENTES, FUNKTIONELLES MITTEL DER ZELLFREIEN SYNTHESE VON PROTEINEN DURCH VERWENDUNG DESSELBEN |
FI20000182A0 (fi) * | 2000-01-28 | 2000-01-28 | Teemu Teeri | Nukleotidisekvenssien käyttö proteiinisynteesin ja proteiinien ilmentämisen lisäämiseksi |
US7981617B2 (en) * | 2000-08-30 | 2011-07-19 | Cellfree Sciences Co., Ltd. | Transcription template for cell-free protein synthesis and method using the same |
JP4723713B2 (ja) * | 2000-09-25 | 2011-07-13 | トヨタ自動車株式会社 | mRNAの潜在的翻訳制御因子のスクリーニング方法 |
FR2815969B1 (fr) | 2000-10-30 | 2004-12-10 | Aventis Cropscience Sa | Plantes tolerantes aux herbicides par contournement de voie metabolique |
JP3750020B2 (ja) * | 2000-12-07 | 2006-03-01 | 学校法人慶應義塾 | C末端修飾タンパク質およびその製造方法、ならびに、c末端修飾タンパク質の製造に用いる修飾剤および翻訳テンプレート、ならびに、c末端修飾タンパク質を用いたタンパク質相互作用の検出方法 |
WO2002068665A2 (en) | 2001-02-22 | 2002-09-06 | Rhobio | Constitutive promoter from arabidopsis |
EP3415625A1 (de) | 2002-02-01 | 2018-12-19 | Life Technologies Corporation | Doppelsträngige oligonukleotide |
US20060009409A1 (en) | 2002-02-01 | 2006-01-12 | Woolf Tod M | Double-stranded oligonucleotides |
WO2003064621A2 (en) * | 2002-02-01 | 2003-08-07 | Ambion, Inc. | HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES |
AU2003276666A1 (en) * | 2002-06-12 | 2003-12-31 | Ambion, Inc. | Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
US20040248094A1 (en) * | 2002-06-12 | 2004-12-09 | Ford Lance P. | Methods and compositions relating to labeled RNA molecules that reduce gene expression |
US20100075423A1 (en) * | 2002-06-12 | 2010-03-25 | Life Technologies Corporation | Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
US20040029275A1 (en) * | 2002-08-10 | 2004-02-12 | David Brown | Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs |
FR2848570B1 (fr) | 2002-12-12 | 2005-04-01 | Bayer Cropscience Sa | Cassette d'expression codant pour une 5-enol pyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides la contenant |
US20060142228A1 (en) * | 2004-12-23 | 2006-06-29 | Ambion, Inc. | Methods and compositions concerning siRNA's as mediators of RNA interference |
WO2007055894A2 (en) | 2005-11-04 | 2007-05-18 | Dow Agrosciences Llc | Preparation of vaccine master cell lines using recombinant plant suspension cultures |
ITUD20060280A1 (it) * | 2006-12-29 | 2008-06-30 | Univ Degli Studi Udine | Sequenza artificiale di dna evente funzione di leader in 5' (5'-utr) ottimizzata per la sovraespressione di proteine eterologhe in pianta |
JP5048524B2 (ja) | 2007-03-08 | 2012-10-17 | 住友化学株式会社 | 植物における、化学物質による外来遺伝子の誘導発現方法 |
CA2739192A1 (en) * | 2008-10-01 | 2010-04-08 | Tet Systems Gmbh & Co.Kg | Tetracycline inducible transcription control sequence |
AR074941A1 (es) | 2009-01-07 | 2011-02-23 | Bayer Cropscience Sa | Plantas transplastomicas exentas de marcador de seleccion |
US9057072B2 (en) | 2009-11-24 | 2015-06-16 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Banana promoters |
AR079881A1 (es) | 2009-12-23 | 2012-02-29 | Bayer Cropscience Ag | Plantas tolerantes a herbicidas inhibidores de las hppd |
EP2516630B1 (de) | 2009-12-23 | 2017-11-15 | Bayer Intellectual Property GmbH | HPPD-Inhibitorherbizid-resistente Pflanzen |
MX2012007358A (es) | 2009-12-23 | 2012-11-06 | Bayer Ip Gmbh | Plantas tolerantes a herbicidas inhibidores de las hppd. |
EA201290572A1 (ru) | 2009-12-23 | 2013-05-30 | Байер Интеллектуэль Проперти Гмбх | Растения, устойчивые к гербицидам - ингибиторам hppd |
ES2659086T3 (es) | 2009-12-23 | 2018-03-13 | Bayer Intellectual Property Gmbh | Plantas tolerantes a herbicidas inhibidores de HPPD |
US20120311743A1 (en) | 2010-02-02 | 2012-12-06 | Bayer Cropscience Ag | Soybean transformation using hppd inhibitors as selection agents |
EP2531602B1 (de) | 2010-02-04 | 2017-05-03 | Bayer Intellectual Property GmbH | Verfahren zur erhöhung der photosynthetischen kohlenstofffixierung |
EP2453012B1 (de) | 2010-11-10 | 2016-06-01 | Bayer CropScience AG | HPPD-Varianten und Anwendungsverfahren |
EP2468882A1 (de) | 2010-12-27 | 2012-06-27 | Bayer CropScience AG | Aurorakinaseaktivatorpolypeptide zum Identifizieren von fungizid wirksamen Verbindungen |
BR112013018531A2 (pt) | 2011-01-24 | 2016-10-18 | Bayer Cropscience Nv | uso do promotor rd29 ou fragmentos do mesmo para expressão induzível por estresse de transgenes em algodão |
JP5847921B2 (ja) | 2011-03-25 | 2016-01-27 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | Hppd阻害薬型除草剤に対して耐性であるトランスジェニック作物の区域で望ましくない植物を防除するためのn−(テトラゾール−4−イル)−もしくはn−(トリアゾール−3−イル)アリールカルボキサミド類またはそれらの塩の使用 |
EP2688407B1 (de) | 2011-03-25 | 2015-04-22 | Bayer Intellectual Property GmbH | Verwendung von n-(1,2,5-oxadiazol-3-yl)benzamiden zur kontrolle des wachstums von unerwünschten pflanzen in bereichen mit transgenen nutzpflanzen mit toleranz gegenüber hppd-inhibitorherbiziden |
WO2012136788A1 (en) | 2011-04-07 | 2012-10-11 | Bayer Cropscience Nv | Seed - specific promoter in cotton |
CN103562386A (zh) | 2011-05-25 | 2014-02-05 | 国立大学法人冈山大学 | Reic表达腺病毒载体 |
EP2742059A1 (de) | 2011-08-12 | 2014-06-18 | Bayer CropScience NV | Schliesszellspezifische expression von transgenen in baumwolle |
WO2013026740A2 (en) | 2011-08-22 | 2013-02-28 | Bayer Cropscience Nv | Methods and means to modify a plant genome |
US20140251317A1 (en) | 2011-10-12 | 2014-09-11 | Bayer Cropscience Ag | Plants with decreased activity of a starch dephosphorylating enzyme |
WO2013053730A1 (en) | 2011-10-12 | 2013-04-18 | Bayer Cropscience Ag | Plants with decreased activity of a starch dephosphorylating enzyme |
UY35035A (es) | 2012-09-14 | 2014-04-30 | Bayer Cropscience Ag | ?molécula de ácido nucleico recombinante que codifica una enzima hppd, vector, célula huésped, semilla, planta, polipéptido, producto primario, métodos y usos?. |
AU2014211570A1 (en) | 2013-01-29 | 2015-07-23 | The University Court Of The University Of Glasgow | Methods and means for increasing stress tolerance and biomass in plants |
CA2917105C (en) | 2013-07-01 | 2023-09-26 | Bayer Cropscience Nv | Methods and means for modulating flowering time in monocot plants |
US11459579B2 (en) | 2013-07-09 | 2022-10-04 | Board Of Trustees Of Michigan State University | Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto |
US10570409B2 (en) | 2013-07-09 | 2020-02-25 | Board Of Trustees Of Michigan State University | Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto |
US10093907B2 (en) | 2013-09-24 | 2018-10-09 | Basf Se | Hetero-transglycosylase and uses thereof |
CN106459986B (zh) | 2014-03-11 | 2020-06-30 | 拜耳作物科学有限合伙公司 | Hppd变体和使用方法 |
CA2957921A1 (en) | 2014-07-22 | 2016-01-28 | Nmc, Inc. | Improved carbon fixation systems in plants and algae |
WO2016050512A1 (en) | 2014-10-03 | 2016-04-07 | Bayer Cropscience Nv | Methods and means for increasing stress tolerance and biomass in plants |
MA41180A (fr) | 2014-12-17 | 2017-10-24 | Bayer Cropscience Nv | Plantes caractérisées par une capacité améliorée de fixation du carbone photosynthétique |
WO2017042259A1 (en) | 2015-09-11 | 2017-03-16 | Bayer Cropscience Aktiengesellschaft | Hppd variants and methods of use |
WO2017184727A1 (en) | 2016-04-21 | 2017-10-26 | Bayer Cropscience Lp | Tal-effector mediated herbicide tolerance |
US20190225974A1 (en) | 2016-09-23 | 2019-07-25 | BASF Agricultural Solutions Seed US LLC | Targeted genome optimization in plants |
BR112019010476A2 (pt) | 2016-11-23 | 2019-09-10 | BASF Agricultural Solutions Seed US LLC | molécula de ácido nucleico recombinante, vetor, célula hospedeira, planta transgênica, semente transgênica, polipeptídeo recombinante, composição, método para controlar uma população de pragas, para matar pragas, para produzir um polipeptídeo, planta ou célula vegetal, método para proteger uma planta contra uma praga, para aumentar o rendimento em uma planta, uso e produto primário |
WO2018119336A1 (en) | 2016-12-22 | 2018-06-28 | Athenix Corp. | Use of cry14 for the control of nematode pests |
BR112019014727A2 (pt) | 2017-01-18 | 2020-04-07 | BASF Agricultural Solutions Seed US LLC | molécula de ácido nucleico, vector, célula, planta, semente, polipeptídeo, composição, métodos para o controle de uma população de pragas, para matar uma praga, para produzir um polipeptídeo, para proteger uma planta e para aumentar o rendimento em uma planta, uso do ácido nucleico e produto de base |
UY37570A (es) | 2017-01-18 | 2018-08-31 | Bayer Cropscience Lp | Uso de bp005 para el control de patógenos de planta |
CN117224710A (zh) | 2017-02-01 | 2023-12-15 | 莫得纳特斯公司 | 编码活化致癌基因突变肽的免疫调节治疗性mrna组合物 |
BR112019018056A2 (pt) | 2017-03-07 | 2020-08-11 | BASF Agricultural Solutions Seed US LLC | molécula de ácido nucleico recombinante, cassete de expressão, célula hospedeira, plantas, sementes transgênicas, polipeptídeo recombinante, métodos para conferir tolerância e para controlar ervas daninhas, produto de utilidade e uso da sequência de nucleotídeos |
EP3625345B1 (de) | 2017-05-18 | 2023-05-24 | ModernaTX, Inc. | Modifizierte messenger-rna mit funktionellen rna-elementen |
WO2018232006A1 (en) | 2017-06-14 | 2018-12-20 | Modernatx, Inc. | Polynucleotides encoding coagulation factor viii |
US11279944B2 (en) | 2017-10-24 | 2022-03-22 | BASF Agricultural Solutions Seed US LLC | Of herbicide tolerance to 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors by down-regulation of HPPD expression in soybean |
WO2019083808A1 (en) | 2017-10-24 | 2019-05-02 | Basf Se | IMPROVING HERBICIDE TOLERANCE AGAINST HPPD INHIBITORS BY REGULATION OF PUTATIVE REDUCED 4-HYDROXYPHENYLPYRUVATE REDUCES IN SOYBEANS |
MA50802A (fr) | 2017-11-22 | 2020-09-30 | Modernatx Inc | Polynucléotides codant pour des sous-unités alpha et bêta de propionyl-coa carboxylase pour le traitement de l'acidémie propionique |
MA50801A (fr) | 2017-11-22 | 2020-09-30 | Modernatx Inc | Polynucléotides codant pour la phénylalanine hydroxylase pour le traitement de la phénylcétonurie |
CA3079428A1 (en) | 2017-11-22 | 2019-05-31 | Modernatx, Inc. | Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders |
WO2019200171A1 (en) | 2018-04-11 | 2019-10-17 | Modernatx, Inc. | Messenger rna comprising functional rna elements |
WO2019233349A1 (zh) | 2018-06-04 | 2019-12-12 | 青岛清原化合物有限公司 | 突变型对羟苯基丙酮酸双氧化酶、其编码核酸以及应用 |
US20220184185A1 (en) | 2018-07-25 | 2022-06-16 | Modernatx, Inc. | Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders |
WO2020047201A1 (en) | 2018-09-02 | 2020-03-05 | Modernatx, Inc. | Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency |
US20220243182A1 (en) | 2018-09-13 | 2022-08-04 | Modernatx, Inc. | Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease |
MA53609A (fr) | 2018-09-13 | 2021-07-21 | Modernatx Inc | Polynucléotides codant la glucose-6-phosphatase pour le traitement de la glycogénose |
AU2019339430A1 (en) | 2018-09-14 | 2021-04-29 | Modernatx, Inc. | Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide A1 for the treatment of Crigler-Najjar Syndrome |
US20220152225A1 (en) | 2018-09-27 | 2022-05-19 | Modernatx, Inc. | Polynucleotides encoding arginase 1 for the treatment of arginase deficiency |
JP2022532078A (ja) | 2019-05-08 | 2022-07-13 | アストラゼネカ アクチボラグ | 皮膚及び創傷のための組成物並びにその使用の方法 |
WO2020263985A1 (en) | 2019-06-24 | 2020-12-30 | Modernatx, Inc. | Messenger rna comprising functional rna elements and uses thereof |
EP4045076A1 (de) | 2019-10-15 | 2022-08-24 | ModernaTX, Inc. | Für granulozytenmakrophagenkolonie-stimulierenden faktor codierende mrnas zur behandlung von morbus parkinson |
JP2022552371A (ja) | 2019-10-15 | 2022-12-15 | モデルナティエックス インコーポレイテッド | 免疫調節ポリペプチドをコードするmRNA及びその使用 |
WO2021142280A1 (en) | 2020-01-10 | 2021-07-15 | Modernatx, Inc. | Methods of making tolerogenic dendritic cells |
EP4096720A2 (de) | 2020-01-30 | 2022-12-07 | ModernaTX, Inc. | Für metabolische umprogrammierungspolypeptide codierende mrnas und deren verwendungen |
WO2021231854A1 (en) | 2020-05-14 | 2021-11-18 | Modernatx, Inc. | Lnp compositions comprising an mrna therapeutic and an effector molecule |
JP2023527875A (ja) | 2020-06-01 | 2023-06-30 | モダーナティエックス・インコーポレイテッド | フェニルアラニンヒドロキシラーゼバリアント及びその使用 |
US20230242908A1 (en) | 2020-06-23 | 2023-08-03 | Modernatx, Inc. | Lnp compositions comprising mrna therapeutics with extended half-life |
WO2022204390A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof |
US11566262B2 (en) | 2021-03-24 | 2023-01-31 | Dna Twopointo Inc. | Tetracycline-inducible expression systems |
WO2022204371A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof |
WO2022204380A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof |
WO2022204369A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia |
JP2024512026A (ja) | 2021-03-24 | 2024-03-18 | モデルナティエックス インコーポレイテッド | オルニチントランスカルバミラーゼ欠損症の治療を目的とした脂質ナノ粒子及びオルニチントランスカルバミラーゼをコードするポリヌクレオチド |
WO2022271776A1 (en) | 2021-06-22 | 2022-12-29 | Modernatx, Inc. | Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome |
WO2023056044A1 (en) | 2021-10-01 | 2023-04-06 | Modernatx, Inc. | Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease |
WO2023196399A1 (en) | 2022-04-06 | 2023-10-12 | Modernatx, Inc. | Lipid nanoparticles and polynucleotides encoding argininosuccinate lyase for the treatment of argininosuccinic aciduria |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1192510A (en) * | 1981-05-27 | 1985-08-27 | Lawrence E. Pelcher | Rna plant virus vector or portion thereof, a method of construction thereof, and a method of producing a gene derived product therefrom |
DE3485850T2 (de) * | 1983-11-08 | 1993-01-21 | Teijin Ltd | Genfragmente, abgeleitet vom menschlichen immunoglobulin-gen. |
DE3431140A1 (de) * | 1984-08-24 | 1986-03-06 | Behringwerke Ag, 3550 Marburg | Enhancer fuer eukaryotische expressionssysteme |
CA1288073C (en) * | 1985-03-07 | 1991-08-27 | Paul G. Ahlquist | Rna transformation vector |
US5466788A (en) * | 1985-03-07 | 1995-11-14 | Mycogen Plant Science, Inc. | Subgenomic promoter |
JPS629984A (ja) * | 1985-07-08 | 1987-01-17 | Ookura Eng Kk | 自動選字装置 |
US4820639A (en) * | 1985-12-04 | 1989-04-11 | Massachusetts Institute Of Technology | Process for enhancing translational efficiency of eukaryotic mRNA |
CA1318619C (en) * | 1986-04-09 | 1993-06-01 | Brian William Grinnell | Method of using eukaryotic expression vectors comprising the bk virus enhancer |
US4962028A (en) * | 1986-07-09 | 1990-10-09 | Dna Plant Technology Corporation | Plant promotors |
-
1986
- 1986-06-04 GB GB868613481A patent/GB8613481D0/en active Pending
-
1987
- 1987-06-04 AT AT87903719T patent/ATE110412T1/de not_active IP Right Cessation
- 1987-06-04 DE DE3750422T patent/DE3750422T2/de not_active Expired - Lifetime
- 1987-06-04 JP JP62503414A patent/JP2814433B2/ja not_active Expired - Lifetime
- 1987-06-04 GB GB8801508A patent/GB2199328B/en not_active Expired - Lifetime
- 1987-06-04 EP EP87903719A patent/EP0270611B1/de not_active Expired - Lifetime
- 1987-06-04 WO PCT/GB1987/000390 patent/WO1987007644A1/en active IP Right Grant
- 1987-06-04 AU AU74896/87A patent/AU614062B2/en not_active Expired
-
1993
- 1993-04-12 US US08/046,358 patent/US5489527A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/474,010 patent/US5891665A/en not_active Expired - Lifetime
-
1997
- 1997-08-25 JP JP22837197A patent/JP3658654B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5489527A (en) | 1996-02-06 |
EP0270611B1 (de) | 1994-08-24 |
GB2199328B (en) | 1990-10-24 |
JP3658654B2 (ja) | 2005-06-08 |
JPH01500961A (ja) | 1989-04-06 |
GB2199328A (en) | 1988-07-06 |
GB8801508D0 (en) | 1988-03-16 |
GB8613481D0 (en) | 1986-07-09 |
DE3750422T2 (de) | 1994-12-15 |
AU7489687A (en) | 1988-01-11 |
EP0270611A1 (de) | 1988-06-15 |
US5891665A (en) | 1999-04-06 |
JP2814433B2 (ja) | 1998-10-22 |
ATE110412T1 (de) | 1994-09-15 |
AU614062B2 (en) | 1991-08-22 |
WO1987007644A1 (en) | 1987-12-17 |
JPH10146197A (ja) | 1998-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE110412T1 (de) | Translation von mrna. | |
DE69938255D1 (de) | Verfahren und zusammensetzung zur konservierung von adenoviren | |
AR020054A1 (es) | COMPOSICIoN QUE COMPRENDE UN ADENOVIRUS | |
DK0804163T3 (da) | Forbedret fremgangsmåde til stabilisering af biologiske stoffer under tørring og efterfølgende opbevaring samt præparater deraf | |
IT7927524A0 (it) | Proteine purificate e procedimento per la loro preparazione. | |
IT8422580A0 (it) | Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle. | |
DE3486160T2 (de) | Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben. | |
NO973685L (no) | Multi-tumor avvikende vekstgener | |
ATE273320T1 (de) | Fusogene liposomen | |
BR9105737A (pt) | Processo para reduzir a contaminacao de um produto de amplificacao,conjunto para uso em um tipo de procedimento de amplificacao e processo para amplificar uma sequencia de amplificacao de uma sequencia-alvo | |
DE69202207T2 (de) | Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan. | |
DE3683374D1 (de) | Mikrobielle zusammensetzungen und verfahren zur behandlung vom boden. | |
DE3874019T2 (de) | Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben. | |
HUP0000318A2 (hu) | Tumorvakcina és eljárás előállítására | |
FI931714A0 (fi) | Fukthaerdbar en-komponent polysiloxanfoerening | |
DE69101634T4 (de) | Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus. | |
ES2054612T3 (es) | Secuencias de adn que codifican para proteinas con actividad biologica de los inhibidores husi tipo-i y procedimientos tecnologicos geneticos para la preparacion de estas proteinas. | |
DK0633763T3 (da) | Kosmetiske eller farmaceutiske sammensætninger indeholdende deacylerede glycerophospholipider til topisk brug | |
DE3785530T2 (de) | Verfahren zur Herstellung von L-Arginin. | |
MA19882A1 (fr) | Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides. | |
DE3886213T2 (de) | Verfahren zur Herstellung von Antioxidant-Zubereitungen. | |
DK403384A (da) | Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf | |
DE68917817T2 (de) | Verfahren zur Herstellung von vernetzten Polycarbonaten und Zusammensetzungen daraus. | |
KR900700604A (ko) | 오이 모자이크 바이러스 코트 단백질 유전자 | |
DK0653939T3 (da) | Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: COPERNICUS TECHNOLOGY LTD., TORTOLA, VG |
|
8365 | Fully valid after opposition proceedings |